日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prediction of survival and outcomes with depth of response at 6 months in metastatic non-small-cell lung cancer patients treated with chemotherapy and immunotherapy combination: SPORE trial

SPORE试验:化疗联合免疫疗法治疗转移性非小细胞肺癌患者,6个月时反应深度与生存率和预后的关系预测

Moinard-Butot, F; Barbe-Richaud, J-B; Lasvergnas, J; Ancel, J; Justeau, G; Le Floch, H; Somme, L; Chouaid, C; Bylicki, O; Schott, R

Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC

度伐利尤单抗联合放化疗治疗不可切除的III期非小细胞肺癌的真实世界5年疗效

Girard, N; Bar, J; Baas, P; Chouaid, C; Christoph, D C; Field, J K; Fietkau, R; Garassino, M C; Garrido Lopez, P; Gregorc, V; Haakensen, V D; Hiltermann, T J N; Kao, S; McDonald, F; Mornex, F; Moskovitz, M; Peters, S; Siva, S; Solomon, B; Qiao, Y; Anand, S; Chander, P; Shcherbakova, T; Diaz Perez, I; Filippi, A R

Real-World Clinical Outcomes and Treatment Patterns in Advanced/Metastatic EGFR-Mutant NSCLC After Progression on First-Line Osimertinib for French Patients

法国患者一线奥希替尼治疗进展后,晚期/转移性EGFR突变型非小细胞肺癌的真实世界临床结果和治疗模式

Girard, Nicolas; Macouillard, Pauline; Byng, Danalyn; Meng, Jie; Coerts, Friso; Hunter, Shannon; Struebing, Alessandria; Xiong, Yan; Park, Sarah; Haq, M Inaam; Tymejczyk, Olga; Chouaid, Christos; Audigier-Valette, Clarisse; Debieuvre, Didier; Quantin, Xavier; Bosquet, Lise; Pérol, Maurice

Real-World Treatment Patterns and Survival in Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe

加拿大和欧洲ROS1阳性晚期非小细胞肺癌患者的真实世界治疗模式和生存情况

Cheung, Winson Y; Lee, Adam; Bote de Cabo, Helena; Burdenski, Kathrin; Christopoulos, Petros; Pinto-Correia, Bárbara; Deshayes, Simon; Girard, Nicolas; Hindocha, Pooja; Madden, Áine; Mella, Marta; Moreira, Joana; Rizzi, Silvia; Abreu, Delvys Rodríguez; Soares, Marta; Thomas, Joseph; Han, Maria; Calvet, Christophe Y; Emanuel, Gabrielle; Glassberg, Mrudula B; Jacobs, Hazel; Rault, Caroline; Yuan, Yong; Chouaid, Christos

Optimisation and validation of line-of-therapy advancement algorithms in advanced/metastatic non-small-cell lung cancer: an I-O Optimise study

晚期/转移性非小细胞肺癌治疗线推进算法的优化与验证:一项 IO Optimise 研究

Lay-Flurrie, S; Greystoke, A; Rault, C; Wolf, A; Riaz, M; Leal, C; de Abreu E Lima, F; Van Naarden Braun, K; Evans-Cheung, T; Glassberg, M B; Eccles, L J; Cheeseman, S; Chouaid, C; Baas, P

Clinical factors influencing retreatment with anti-PD-(L)1 therapies after treatment in early-stage cancers: a modified Delphi consensus study

早期癌症治疗后接受抗PD-(L)1疗法再治疗的影响因素:一项改良的德尔菲共识研究

Pusztai, Lajos; Sondak, Vernon K; Aguiar-Ibáñez, Raquel; Cappuzzo, Federico; Chouaid, Christos; Elder, Chris; Hirasawa, Yosuke; Ishida, Masaru; Jones, Robert; Lee, Seung Hyeun; Mizuno, Ryuichi; Nagata, Masayoshi; Okonji, David; Parente, Phillip; Shah, Bhavesh; Sun, Alexander; Ferreira, Dominihemberg; Spiteri, Carmel; Lauer, Andrea; Kaliasethi, Amrit; Kao, Carol; Kothari, Smita; McKendrick, Jan

Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trial

在不可切除的 III 期非小细胞肺癌患者中,序贯放化疗后使用度伐利尤单抗治疗——来自 II 期 PACIFIC-6 试验的最终分析

Garassino, M C; Khalifa, J; Reck, M; Chouaid, C; Bischoff, H; Reinmuth, N; Cove-Smith, L; Mansy, T; Cortinovis, D L; Migliorino, M R; Delmonte, A; Garcia Sánchez, J; Chara Velarde, L E; Bernabe, R; Paz-Ares, L; Chander, P; Diaz Perez, I; Foroutanpour, K; Emeribe, U; Faivre-Finn, C

Compassionate Access to Brigatinib for Patients with Non-small-cell Lung Cancer Harboring a ROS1 Rearrangement: Results from the BRIGAROS Study

为携带 ROS1 重排的非小细胞肺癌患者提供 Brigatinib 的同情用药:BRIGAROS 研究的结果

Mourlanette, Jean; Rousseau-Bussac, Gaelle; Mallah, Siham; Guisier, Florian; Zalcman, Gerard; Veillon, Rémi; Audigier-Valette, Clarisse; Roa, Magali; Nicolle, Isabelle; Doubre, Helene; Cloarec, Nicolas; Lamy, Régine; Morel, Hugues; Curcio, Hubert; Lagrange, Aurélie; Schott, Roland; Sabatini, Marielle; Toffart, Anne Claire; Pinsolle, Julian; Bennouna, Jaafar; Chouaid, Christos; Mazieres, Julien

Recurrence as a small cell lung cancer transformation in a resected stage IIIA EGFR-mutated non-small cell lung cancer treated with adjuvant osimertinib: a case report

一例接受奥希替尼辅助治疗的IIIA期EGFR突变型非小细胞肺癌切除术后复发并转化为小细胞肺癌的病例报告

Lasvergnas, Julie; Monnet, Isabelle; Auliac, Jean-Bernard; Rousseau-Bussac, Gaelle; Chouaid, Christos; Assié, Jean-Baptiste

Real-World Outcomes of Pralsetinib in RET Fusion-Positive NSCLC

普拉替尼治疗RET融合阳性非小细胞肺癌的真实世界疗效

Lucibello, Francesca; Gounant, Valérie; Aldea, Mihaela; Duruisseaux, Michaël; Perol, Maurice; Chouaid, Christos; Bennouna, Jaafar; Fallet, Vincent; Renault, Aldo; Guisier, Florian; Giroux-Leprieur, Etienne; Wislez, Marie; Toffart, Anne-Claire; Mazieres, Julien; Basse, Clémence; Hegarat, Nadia; Carton, Matthieu; Girard, Nicolas